Stock futures are trading slightly higher this morning as investors digest the delayed jobs report release and recent mixed earnings. Employers added 130,000 jobs in January, according to the Labor Department. This comes in a report pushed back from last week by a government shutdown. The unemployment rate dipped to 4.3% from 4.4% in December. Retail sales data showing weaker consumer spending has softened risk appetite and boosted expectations for potential future Federal Reserve rate cuts.
Claim 30% Off TipRanks
Trade U with leverageAt the same time, commodities such as oil and precious metals have drawn interest, with oil prices rising on geopolitical tension and signs of steady demand, and gold and silver climbing as yields soften and safe-haven demand persists amid economic uncertainty.
In pre-market trading, S&P 500 futures rose 0.52%, Nasdaq futures rose 0.69% and Dow futures rose 0.44%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
- Unity (U) down 26%
- Lyft (LYFT) down 15%
- Robinhood (HOOD) down 10%
- Kraft Heinz (KHC) down 8%
- Humana (HUM) down 6%
- T-Mobile (TMUS) down 5%
- Tenet Healthcare (THC) down 3%
LOWER –
- Moderna (MRNA) down 10% after the FDA’s Center for Biologics Evaluation and Research has notified the company that it will not initiate a review of the biologics license application for its investigational influenza vaccine, mRNA-1010, and has issued a refusal-to-file letter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna: FDA Flu Vaccine Setback Adds U.S. Uncertainty but Medium‑Term Outlook Supports Hold Rating
- Moderna price target lowered to $12 from $17 at Leerink
- Moderna Faces FDA Setback on mRNA Flu Vaccine
- Moderna price target lowered to $24 from $27 at BofA
- Regulatory Setback Clouds Moderna’s Flu Franchise and Combo Vaccine Outlook, Justifying Market Perform (Hold) Rating